Cutting Product Loss and Carbon Emissions in Pharma Supply Chains

Sponsored by AeroSafe Global

Jay McHarg, CEO of AeroSafe Global, elaborates on the benefits of Aerosafe’s Targeted Risk Improvement Program (TRIP), which enhances pharmaceutical delivery by focusing on critical metrics like on-time arrival, temperature compliance, and customer acceptance. TRIP uses daily analyses of failed deliveries and monthly reviews of shipping lanes to identify root causes—ranging from closed facilities to route delays—and works collaboratively with partners to implement solutions such as adjusted shipping schedules or modified Service Level Agreements. This approach improves resilience, reduces costs, and strengthens sustainability across the supply chain.

Financially, he explains, Aerosafe treats the last mile as an investment rather than a cost, leveraging reusable packaging programs to amortize technology expenses and achieve high return rates above 98%, reducing product loss and operational risk while increasing reliability and brand trust. High return rates also support sustainability goals, lowering Scope 3 CO₂ emissions and helping companies meet carbon neutrality targets. Central to success is strong collaboration among Aerosafe, distribution operators, and logistics partners, with patient satisfaction as the ultimate measure of delivery excellence.

Want to continue watching this interview? Click here.